- Vivus filed for bankruptcy in Delaware and listed as much as $500m of assets and liabilities each in its petition
- IEH Biopharma is a subsidiary of Icahn Enterprises
- Vivus wants to have the reorganization plan confirmed by court on August 17, per statement
- Co. will continue its clinical and commercial operations, including the sales and marketing of weight management medication and other drugs, ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.